Allergy Immunotherapy in the Management of Eosinophilic Esophagitis

NCT01685034 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Researcher deployed before approval

Conditions

Eosinophilic Esophagitis

Interventions

BIOLOGICAL: Allergy immunotherapy ("allergy shots")

Sponsor

United States Naval Medical Center, San Diego